Astra Industrial Group announces its Interim Financial results for the Period Ending on 2025-09-30 ( Nine Months )

Sales/Revenue

730,058,449

688,527,042

6.031

715,112,301

2.09

Gross Profit (Loss)

346,013,712

324,022,859

6.786

326,588,983

5.947

Operational Profit (Loss)

182,083,158

164,375,553

10.772

203,614,307

-10.574

Net profit (Loss)

167,442,561

139,413,626

20.104

174,924,439

-4.277

Total Comprehensive Income

169,711,204

143,205,116

18.509

174,796,305

-2.909

Sales/Revenue

2,278,898,920

2,340,660,188

-2.638

Gross Profit (Loss)

1,045,200,698

1,011,947,720

3.286

Operational Profit (Loss)

574,998,580

496,648,352

15.775

Net profit (Loss)

514,238,096

457,902,329

12.303

Total Comprehensive Income

521,230,635

460,801,778

13.113

Total Shareholders Equity (after Deducting Minority Equity)

2,805,036,713

2,388,704,390

17.429

Profit (Loss) per Share

6.43

5.72

Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value

–

–

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is

Revenue increase in general due to:

Increase in revenue in the following segments:
a) Steel
b) Pharmaceuticals
While noting that there is decrease in revenue in Specialty Chemical segment.

The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is

Net profit Increases in general due to:
1. Increase in Gross Profit in Steel segment.
2. Decrease in financial costs mainly in Specialty Chemical segment.
3. Decrease in expense for impairment of financial assets mainly in the Steel segment.

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is

Revenue increase in general due to:

Increase in revenue in the following segments:
a) Pharmaceuticals
b) Steel
While noting that there is decrease in revenue in Specialty Chemical segment.

The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is

Net profit Decreases in general due to:
1. Lower general and administration expenses in the previous quarter in Steel segment.
2. Increase in zakat and income tax expenses in Specialty chemical segment.

While noting that there is increase in Gross Profit in Pharmaceuticals segment.

The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is

Revenue decreases in general due to:

Decrease in revenue in the following segments:
a) Steel
b) Specialty chemical
While noting that there is increase in revenue in Pharmaceuticals segment.

The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is

Net profit Increases in general due to:
1. Decrease in general and administrative expenses in the Steel segment.
2. Decrease in financial costs mainly in Specialty Chemical segment.
3. Increase in Gross Profit in the following segments:
a) Steel
b) Pharmaceuticals
While noting that there is Gain from discontinued operation in similar period last year.

Statement of the type of external auditor’s report

Unmodified conclusion

Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)

NA

Reclassification of Comparison Items

Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.

Additional Information

Net Shareholders’ Equity at the end of the period was SR 2,826,326,481/- compared to SR 2,395,855,591/- at the end of the similar period last year with an increase of 18%.